|
1
|
Gabriel V: Hypertrophic scar. Phys Med
Rehabil Clin N Am. 22:301–310. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fan SQ, Cai JL, Qin LY, Wang ZH, Liu ZZ
and Sun ML: Effect of heparin on production of transforming growth
factor (TGF)-betal and TGF-betal mRNA expression by human normal
skin and hyperplastic scar fibroblasts. Ann Plast Surg. 60:299–305.
2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gauglitz GG, Korting HC, Pavicic T,
Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids:
Pathomechanisms and current and emerging treatment strategies. Mol
Med. 17:113–125. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sidgwick GP, Iqbal SA and Bayat A: Altered
expression of hyaluronan synthase and hyaluronidase mRNA may affect
hyaluronic acid distribution in keloid disease compared with normal
skin. Exp Dermatol. 22:377–379. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Syed F, Ahmadi E, Iqbal SA, Singh S,
McGrouther DA and Bayat A: Fibroblasts from the growing margin of
keloid scars produce higher levels of collagen I and III compared
with intralesional and extralesional sites: Clinical implications
for lesional site-directed therapy. Br J Dermatol. 164:83–96.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zuccaro J, Ziolkowski N and Fish J: A
systematic review of the effectiveness of laser therapy for
hypertrophic burn scars. Clin Plast Surg. 44:767–779.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu X, Lai L, Zhang X, Chen J, Chen J, Wang
F, Zheng J and Chen M: Autologous chyle fat grafting for the
treatment of hypertrophic scars and scar-related conditions. Stem
Cell Res Ther. 9(64)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rogers K and Chen X: Biogenesis, turnover,
and mode of action of plant microRNAs. Plant Cell. 25:2383–2399.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wojtas B, Ferraz C, Stokowy T, Hauptmann
S, Lange D, Dralle H, Musholt T, Jarzab B, Paschke R and Eszlinger
M: Differential miRNA expression defines migration and reduced
apoptosis in follicular thyroid carcinomas. Mol Cell Endocrinol.
388:1–9. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mu S, Kang B, Zeng W, Sun Y and Yang F:
MicroRNA-143-3p inhibits hyperplastic scar formation by targeting
connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
Mol Cell Biochem. 416:99–108. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hao XZ and Fan HM: Identification of
miRNAs as atherosclerosis biomarkers and functional role of miR-126
in atherosclerosis progression through MAPK signalling pathway. Eur
Rev Med Pharmacol Sci. 21:2725–2733. 2017.PubMed/NCBI
|
|
15
|
Bi S, Chai L, Yuan X, Cao C and Li S:
MicroRNA-98 inhibits the cell proliferation of human hypertrophic
scar fibroblasts via targeting Col1A1. Biol Res.
50(22)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhu HY, Li C, Bai WD, Su LL, Liu JQ, Li Y,
Shi JH, Cai WX, Bai XZ, Jia YH, et al: MicroRNA-21 regulates hTERT
via PTEN in hypertrophic scar fibroblasts. PLoS One.
9(e97114)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qu F, Ye J, Pan X, Wang J, Gan S, Chu C,
Chu J, Zhang X, Liu M, He H and Cui X: MicroRNA-497-5p
down-regulation increases PD-L1 expression in clear cell renal cell
carcinoma. J Drug Target. 27:67–74. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR,
Ding Y, Liang JQ, Li TT and Zhao J: MiR-497-5p, miR-195-5p and
miR-455-3p function as tumor suppressors by targeting hTERT in
melanoma A375 cells. Cancer Manag Res. 10:989–1003. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sun Z, Li A, Yu Z, Li X, Guo X and Chen R:
MicroRNA-497-5p suppresses tumor cell growth of osteosarcoma by
targeting ADP ribosylation factor-like protein 2. Cancer Biother
Radiopharm. 32:371–378. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen Y, Kuang D, Zhao X, Chen D, Wang X,
Yang Q, Wan J, Zhu Y, Wang Y, Zhang S, et al: miR-497-5p inhibits
cell proliferation and invasion by targeting KCa3.1 in
angiosarcoma. Oncotarget. 7:58148–58161. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang
Z, Hu K, Dong P and Han X: The role of miR-497-5p in myofibroblast
differentiation of LR-MSCs and pulmonary fibrogenesis. Sci Rep.
7(40958)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nakao A, Afrakhte M, Morén A, Nakayama T,
Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH
and ten Dijke P: Identification of Smad7, a TGFbeta-inducible
antagonist of TGF-beta signalling. Nature. 389:631–635.
1997.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Kavsak P, Rasmussen RK, Causing CG, Bonni
S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an
E3 ubiquitin ligase that targets the TGF beta receptor for
degradation. Mol Cell. 6:1365–1375. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yeung ML, Yao Y, Jia L, Chan JFW, Chan KH,
Cheung KF, Chen H, Poon VKM, Tsang AKL, To KKW, et al: MERS
coronavirus induces apoptosis in kidney and lung by upregulating
Smad7 and FGF2. Nat Microbiol. 1(16004)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C,
Liu X, Zhang R and Wang Y: Praziquantel ameliorates
CCl4-induced liver fibrosis in mice by inhibiting
TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate
cells. Br J Pharmacol. 176:4666–4680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou R, Wang C, Wen C and Wang D: miR-21
promotes collagen production in keloid via Smad7. Burns.
43:555–561. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen Z, Liu Y, Xiao M, Xiao H, Qiu W and
Zhao Y: Effects of over-expressing smad7 gene on keloid
fibroblasts. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 30:871–875.
2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
28
|
Tao J, Wang J, Li C, Wang W, Yu H, Liu J,
Kong X and Chen Y: MiR-216a accelerates proliferation and
fibrogenesis via targeting PTEN and SMAD7 in human cardiac
fibroblasts. Cardiovasc Diagn Ther. 9:535–544. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lee HJ and Jang YJ: Recent understandings
of biology, prophylaxis and treatment strategies for hypertrophic
scars and keloids. Int J Mol Sci. 19(711)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Aberdam D, Candi E, Knight RK and Melino
G: miRNAs, ‘sternness’ and skin. Trends Biochem Sci. 33:583–591.
2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Botchkareva NV: MicroRNA/mRNA regulatory
networks in the control of skin development and regeneration. Cell
Cycle. 11:468–474. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen L and Li J, Li Q, Yan H, Zhou B, Gao
Y and Li J: Non-coding RNAs: The new insight on hypertrophic scar.
J Cell Biochem. 118:1965–1968. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tsai CH and Ogawa R: Keloid research:
Current status and future directions. Scars Burn Heal.
5(2059513119868659)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang Q, Guo B, Hui Q, Chang P and Tao K:
miR-137 inhibits proliferation and metastasis of hypertrophic scar
fibroblasts via targeting pleiotrophin. Cell Physiol Biochem.
49:985–995. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu X, Li J, Yang X, Bai X, Shi J, Gao J,
Li Y, Han S, Zhang Y, Han F, et al: miR-155 inhibits the formation
of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT
pathway. J Mol Histol. 49:377–387. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhou X, Xie Y, Xiao H, Deng X, Wang Y,
Jiang L, Liu C and Zhou R: MicroRNA-519d inhibits proliferation and
induces apoptosis of human hypertrophic scar fibroblasts through
targeting Sirtuin 7. Biomed Pharmacother. 100:184–190.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang X, Zhang Y, Jiang BH, Zhang Q, Zhou
RP, Zhang L and Wang C: Study on the role of Hsa-miR-31-5p in
hypertrophic scar formation and the mechanism. Exp Cell Res.
361:201–209. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zunwen L, Shizhen Z, Dewu L, Yungui M and
Pu N: Effect of tetrandrine on the TGF-β-induced smad signal
transduction pathway in human hypertrophic scar fibroblasts in
vitro. Burns. 38:404–413. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu B, Li J and Cairns MJ: Identifying
miRNAs, targets and functions. Brief Bioinform. 15:1–19.
2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar
|
